SAN FRANCISCO, March 13, 2025 (GLOBE NEWSWIRE) -- Montara Therapeutics, a biotech company pioneering brain-selective therapies for CNS diseases, today announced the closing of a $20 million ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback